Overview

Study of the GARFT Inhibitor AG2037 in Patients With Metastatic Colorectal Cancer Who Failed Treatment

Status:
Completed
Trial end date:
2004-09-01
Target enrollment:
Participant gender:
Summary
To determine the response rate in patients with metastatic colorectal cancer who failed treatment with a 5-Fluorouracil/Leucovorin regimen and up to one other chemotherapeutic regimen (not including adjuvant chemotherapy).
Phase:
Phase 2
Details
Lead Sponsor:
Pfizer